Finepoint Capital LP Xencor Inc Transaction History
Finepoint Capital LP
- $1.18 Billion
- Q4 2024
A detailed history of Finepoint Capital LP transactions in Xencor Inc stock. As of the latest transaction made, Finepoint Capital LP holds 660,000 shares of XNCR stock, worth $10.4 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
660,000Holding current value
$10.4 Million% of portfolio
1.28%Shares
1 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$175 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$141 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$126 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$96.7 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$63.5 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $940M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...